Encouraging data from CDC, Moderna reassures about vaccine efficacy against B117 strain, and Merck shelves its COVID-19 vaccines after disappointing Phase 1.
Share this post
COVID-19 data trending slightly down
Share this post
Encouraging data from CDC, Moderna reassures about vaccine efficacy against B117 strain, and Merck shelves its COVID-19 vaccines after disappointing Phase 1.